Article
Athersys gets accelerated FDA review for therapy treating most frequent cause of Covid death
Rating:
0.0
Views:
69
Likes:
1
Library:
1
The U.S. Food and Drug Administration has granted Athersys Inc. Regenerative Medicine Advanced Therapy, or RMAT, designation for its therapy for acute respiratory distress syndrome, the most frequent cause of death from Covid-19.
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value